2025 ICD-10-CM code G90.3

Multi-system degeneration of the autonomic nervous system (ANS).This rare neurodegenerative disorder damages nerve cells in the brain and spinal cord, affecting involuntary bodily functions (blood pressure, digestion) and movement.

Use G90.3 for cases where the multi-system degeneration primarily affects the autonomic nervous system.Differentiate from other neurological conditions with similar symptoms.

Medical necessity for interventions and treatments related to G90.3 rests on demonstrating the functional limitations and impact on the patient's quality of life due to ANS dysfunction.

Diagnosis is based on medical history, physical examination, and symptoms.There's no single definitive test, but MRI, FDG-PET, and MIBG-SPECT scans can aid differential diagnosis. Other tests include blood work, autonomic function tests, sweat tests, bladder function tests, ECG, and tilt-table tests.

IMPORTANT Related terms include multiple system atrophy (MSA), progressive autonomic failure with MSA, neurogenic orthostatic hypotension, Shy-Drager syndrome (SDS), sporadic olivopontocerebellar atrophy (sOPCA), and striatonigral degeneration (SND).

In simple words: Multi-system atrophy (MSA) is a rare, serious condition where parts of the brain and spinal cord that control automatic functions like blood pressure, digestion, and movement start to deteriorate. It can cause symptoms similar to Parkinson's disease, problems with balance, and other issues like trouble with bladder control or swallowing.Unfortunately, there's no cure, but treatments can help manage the symptoms.

Multi-system degeneration of the autonomic nervous system (ANS), also known as multiple system atrophy (MSA), is a progressive neurodegenerative disorder affecting both the central and peripheral nervous systems.It is characterized by the degeneration of nerve cells in specific areas of the brain and spinal cord, leading to a range of symptoms impacting involuntary functions, movement, and balance. The two primary phenotypes are parkinsonian and cerebellar. Parkinsonian symptoms include slow movement, tremors, rigidity, incoordination, impaired speech, orthostatic hypotension, and bladder control problems. Cerebellar symptoms involve ataxia (balance and coordination issues), difficulty swallowing (dysphagia), speech abnormalities (dysarthria), and abnormal eye movements.

Example 1: A 55-year-old patient presents with progressive difficulty with balance, slurred speech, and occasional urinary incontinence.MRI and clinical findings point towards a diagnosis of MSA with cerebellar predominance (G90.3)., A 60-year-old patient experiences tremors, rigidity, and slow movement, initially diagnosed as Parkinson's disease. However, the development of orthostatic hypotension and urinary incontinence leads to a revised diagnosis of MSA with parkinsonian features (G90.3)., A patient with a history of fainting spells and difficulty regulating blood pressure exhibits other neurological symptoms. After comprehensive testing, including autonomic function tests and imaging studies, a diagnosis of multi-system degeneration of the autonomic nervous system (G90.3) is made.

Documentation should include detailed neurological examination findings, symptoms (e.g., orthostatic hypotension, bladder/bowel dysfunction, movement difficulties), results of imaging studies (MRI, FDG-PET, MIBG-SPECT), autonomic function tests, and other relevant diagnostic reports.

** Treatment is symptomatic and may include medications for movement disorders, blood pressure regulation, and bladder control.Physical and occupational therapy can be beneficial in managing functional limitations.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.